Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Significant Decline in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a significant drop in short interest during the month of August. As of August 14th, there was short interest totaling 400 shares, a drop of 54.4% from the July 30th total of 877 shares. Based on an average daily trading volume, of 2,137 shares, the short-interest ratio is presently 0.2 days. Approximately 0.1% of the shares of the company are short sold.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

Hedge funds have recently modified their holdings of the stock. Osaic Holdings Inc. lifted its stake in Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the last quarter. Comprehensive Wealth Management LLC increased its position in Innovator IBD Breakout Opportunities ETF by 122.0% in the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after buying an additional 12,859 shares during the last quarter. Finally, Susquehanna International Group LLP increased its position in Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after buying an additional 7,817 shares during the last quarter.

Innovator IBD Breakout Opportunities ETF Stock Performance

BOUT stock traded down $0.76 during mid-day trading on Friday, hitting $44.16. The company had a trading volume of 312 shares, compared to its average volume of 3,782. The firm has a market cap of $15.46 million, a PE ratio of 28.69 and a beta of 1.04. Innovator IBD Breakout Opportunities ETF has a 12 month low of $35.05 and a 12 month high of $49.41. The stock’s fifty day moving average price is $46.35 and its two-hundred day moving average price is $44.12.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.